Prestigious Scientific Publications
Situation
- The client has completed a Phase 3 study on a novel therapy, if approved, may become the new standard of care
- The distribution of manuscript and conference publications will facilitate a widespread understanding of the efficacy and safety of the drug and facilitate a successful product launch
Challenge
- A comprehensive publication plan requires a timely and complex management of analytics, medical writing support, client interfacing/buy-in, and Key Opinion Leader (KOL) engagement
- The balance of impending hard publication deadlines with adherence to Good Publication Practices (GPP)
Resolution
- In the same week, Xelay Acumen published scientific trial results in the top two medical journals, New England Journal of Medicine and Journal of American Medical Association